Serum Levels of Leukemia Inhibitory Factor LIF in Wheezy Infants and its Relation with Respiratory Syncytial Virus Infection §

Cilt: 17 Sayı: 1 1 Ocak 2017
  • Zeynep Tamay
  • Kemal Nişli
  • Nermin Güler
  • Deniz Özçeker
  • Ülker Öneş
PDF İndir
TR EN

Serum Levels of Leukemia Inhibitory Factor LIF in Wheezy Infants and its Relation with Respiratory Syncytial Virus Infection §

Öz

Objective: Leukemia inhibitory factor LIF is the most pleiotropic member of the interleukin-6 family of cytokines. It utilises a receptor that consists of the LIF receptor β and gp130 and this receptor complex is also used by ciliary neurotrophic growth factor CNTF , oncostatin M, cardiotrophin1 CT1 and cardiotrophin-like cytokine CLC . Evidence is emerging that LIF may play an important role in airway inflammation. Recurrent wheezing is one of the commonest problems of early childhood and respiratory syncytial virus RSV is the most frequent cause of wheezy episodes. Material and Method: The aim of this study was to determine whether LIF has a role in the airway inflammation of wheezy children and its relationship with RSV infection. Results: Serum LIF levels, total IgE levels, RSV-IgM and RSVIgG antibodies were evaluated in wheezy 22F, 18M and healthy 18F, 20M infants. RSV-IgM antibodies were detected in 25% of wheezy and 3% of healthy children. RSV-IgG antibodies were detected 35% and 23%, respectively. There was not significant difference in median serum levels of LIF between wheezy and healthy infants. However, median serum LIF level of subjects who were seropositive for RSV-IgM antibodies was significantly higher than those who were seronegative for RSV-IgM antibodies 16 pg/ml vs 10.5 pg/ml; p=0.01 . Conclusion: This study suggests that LIF might play a role in early airway inflammation in infants with wheezy RSV infection

Anahtar Kelimeler

Kaynakça

  1. Nicola NA, Babon JJ. Leukemia inhibitory factor (LIF). Cytokine Growth Factor Rev 2015;26(5):533- 44. http://dx.doi.org/10.1016/j.cytogfr.2015.07.001
  2. Metcalf D. Leukemia inhibitory factor-a puzzling poly- functional regulator. Growth Factors 1992:7:169-73. http://dx.doi.org/10.3109/08977199209046921
  3. Metcalf D. The unsolved enigmas of Leukemia inhibi- tory factor. Stem Cells 2003:21:5-14. http://dx.doi.org/10.1634/stemcells.21-1-5
  4. Knight DA, McKay BR, Wiggs RR et al. Localisation of leukemia inhibitory factor to airway epithelium and its amplification of contractile responses to tachyki- nins. Br J Pharmacol 1997:120:883-91. http://dx.doi.org/10.1038/sj.bjp.0700965
  5. Knight DA, Lydell cP, Zhou D et al. Leukemia inhi- bitory factor (LIF) and LIF receptor in human lung: distribution and regulation of LIF release. Am J Respir Cell Mol Biol 1999;20:834-41. http://dx.doi.org/10.1165/ajrcmb.20.4.3429
  6. Zheng X, Knight DA, Zhou D et al. Leukemia inhibi- tory factor is synthesized and released by human eosi- nophils and modulates activation state and chemotaxis. J Allergy Clin Immunol 1999;104:136-44. http://dx.doi.org/10.1016/S0091-6749(99)70125-9
  7. Martinez FD. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J 2003;22:76-82. http://dx.doi.org/10.1097/01.inf.0000053889.39392.a7
  8. Martinez FD, Godfrey S. Wheezing disorders in the preschool child.London: MD Martin Dunitz 2003. http://dx.doi.org/10.3109/9780203624340

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yazarlar

Zeynep Tamay Bu kişi benim

Kemal Nişli Bu kişi benim

Nermin Güler Bu kişi benim

Deniz Özçeker Bu kişi benim

Ülker Öneş Bu kişi benim

Yayımlanma Tarihi

1 Ocak 2017

Gönderilme Tarihi

-

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2017 Cilt: 17 Sayı: 1

Kaynak Göster

APA
Tamay, Z., Nişli, K., Güler, N., Özçeker, D., & Öneş, Ü. (2017). Serum Levels of Leukemia Inhibitory Factor LIF in Wheezy Infants and its Relation with Respiratory Syncytial Virus Infection §. Çocuk Dergisi, 17(1), 12-17. https://doi.org/10.5222/j.child.2017.012
AMA
1.Tamay Z, Nişli K, Güler N, Özçeker D, Öneş Ü. Serum Levels of Leukemia Inhibitory Factor LIF in Wheezy Infants and its Relation with Respiratory Syncytial Virus Infection §. Çocuk Dergisi. 2017;17(1):12-17. doi:10.5222/j.child.2017.012
Chicago
Tamay, Zeynep, Kemal Nişli, Nermin Güler, Deniz Özçeker, ve Ülker Öneş. 2017. “Serum Levels of Leukemia Inhibitory Factor LIF in Wheezy Infants and its Relation with Respiratory Syncytial Virus Infection §”. Çocuk Dergisi 17 (1): 12-17. https://doi.org/10.5222/j.child.2017.012.
EndNote
Tamay Z, Nişli K, Güler N, Özçeker D, Öneş Ü (01 Ocak 2017) Serum Levels of Leukemia Inhibitory Factor LIF in Wheezy Infants and its Relation with Respiratory Syncytial Virus Infection §. Çocuk Dergisi 17 1 12–17.
IEEE
[1]Z. Tamay, K. Nişli, N. Güler, D. Özçeker, ve Ü. Öneş, “Serum Levels of Leukemia Inhibitory Factor LIF in Wheezy Infants and its Relation with Respiratory Syncytial Virus Infection §”, Çocuk Dergisi, c. 17, sy 1, ss. 12–17, Oca. 2017, doi: 10.5222/j.child.2017.012.
ISNAD
Tamay, Zeynep - Nişli, Kemal - Güler, Nermin - Özçeker, Deniz - Öneş, Ülker. “Serum Levels of Leukemia Inhibitory Factor LIF in Wheezy Infants and its Relation with Respiratory Syncytial Virus Infection §”. Çocuk Dergisi 17/1 (01 Ocak 2017): 12-17. https://doi.org/10.5222/j.child.2017.012.
JAMA
1.Tamay Z, Nişli K, Güler N, Özçeker D, Öneş Ü. Serum Levels of Leukemia Inhibitory Factor LIF in Wheezy Infants and its Relation with Respiratory Syncytial Virus Infection §. Çocuk Dergisi. 2017;17:12–17.
MLA
Tamay, Zeynep, vd. “Serum Levels of Leukemia Inhibitory Factor LIF in Wheezy Infants and its Relation with Respiratory Syncytial Virus Infection §”. Çocuk Dergisi, c. 17, sy 1, Ocak 2017, ss. 12-17, doi:10.5222/j.child.2017.012.
Vancouver
1.Zeynep Tamay, Kemal Nişli, Nermin Güler, Deniz Özçeker, Ülker Öneş. Serum Levels of Leukemia Inhibitory Factor LIF in Wheezy Infants and its Relation with Respiratory Syncytial Virus Infection §. Çocuk Dergisi. 01 Ocak 2017;17(1):12-7. doi:10.5222/j.child.2017.012